Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,044
Closed -$230K 479
2026
Q1
$230K Hold
3,044
0.01% 438
2025
Q4
$227K Hold
3,044
0.01% 417
2025
Q3
$205K Buy
+3,044
New +$202K 0.01% 432
2025
Q1
Sell
-3,044
Closed -$219K 472
2024
Q4
$219K Sell
3,044
-55
-2% -$4.3K 0.01% 450
2024
Q3
$252K Buy
+3,099
New +$248K 0.02% 412

Other funds holding HOLX

Equitable Trust's HOLX Position: Q2 2026 in Review

Equitable Trust sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,044 shares — an estimated $230K sold.

Equitable Trust first reported a position in HOLX in Q3 2024 and held it in 5 quarters. The position peaked at $252K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Equitable Trust reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Equitable Trust sold 3,044 Hologic shares in Q2 2026, an estimated $230K.
  • Equitable Trust first reported a position in Hologic in Q3 2024 and held it in 5 quarters.
  • Equitable Trust's Hologic position peaked at $252K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.